The Contemporary Use of Intracoronary Brachytherapy for In-Stent Restenosis: A Review

被引：1
|
作者：
Madanat, Luai [1 ]
Donisan, Teodora [2 ]
Balanescu, Dinu, V [1 ]
Jabri, Ahmad [3 ]
Al-Abdouh, Ahmad [4 ]
Alsabti, Sam [1 ]
Li, Shuo [1 ]
Kheyrbek, Mazhed [1 ]
Mertens, Amy [5 ]
Hanson, Ivan [5 ]
Dixon, Simon [4 ]
机构：
[1] Beaumont Hosp, Dept Internal Med, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA
[2] Mayo Clin, Sch Med, Dept Cardiovasc Med, Rochester, MN USA
[3] Metrohlth Med Ctr, Heart & Vasc Ctr, Dept Cardiovasc Med, Cleveland, OH USA
[4] Univ Kentucky, Dept Internal Med, Lexington, KY USA
[5] Beaumont Hosp, Dept Cardiovasc Med, Royal Oak, MI USA
来源：
CARDIOVASCULAR REVASCULARIZATION MEDICINE | 2023年 / 51卷
关键词：
Brachytherapy; In-stent restenosis; Drug -eluting stent; Intra-coronary imaging; DRUG-ELUTING STENT; GAMMA-RADIATION THERAPY; DUAL ANTIPLATELET THERAPY; BARE-METAL STENTS; PERCUTANEOUS CORONARY INTERVENTION; CATHETER-BASED RADIOTHERAPY; VASCULAR BRACHYTHERAPY; BALLOON ANGIOPLASTY; BETA-RADIATION; FOLLOW-UP;
D O I：
10.1016/j.carrev.2023.01.019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In-stent restenosis (ISR) has been a major limitation in interventional cardiology and constitutes nearly 10 % of all percutaneous coronary interventions in the United States. Drug-eluting stent (DES) restenosis proves particularly difficult to manage and poses a high risk of recurrence and repeat intervention. Intra-coronary brachytherapy (IBT) has been traditionally viewed as a potential treatment modality for ISR. However, its use was hindered by procedural complexity, cost, and the advent of newer-generation DES. Recent data suggests promising results regarding IBT for the treatment of resistant DES-ISR. This review addresses the mechanism of action of IBT, pro-cedural details, and associated risks and complications of its use. It will also highlight the available clinical evi-dence supporting the use of IBT and the future directions of its utilization in the treatment of ISR.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码：67 / 74
页数：8
相关论文
共 50 条
  • [21] Intracoronary Optical Coherence Tomography for the Assessment of In-Stent Restenosis
    Rayoo, Rinku
    Tuer, Zoe
    Sharma, Naveen
    Barlis, Peter
    HEART LUNG AND CIRCULATION, 2011, 20 (05) : 332 - 335
  • [22] Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy
    Kuchulakanti, Pramod
    Wolfram, Roswitha
    Torguson, Rebecca
    Rha, Seung-Woon
    Cheneau, Edouard
    Clavijo, Leonardo
    Chu, William W.
    Pinnow, Ellen E.
    Canos, Daniel
    Satler, Lowell F.
    Suddath, William O.
    Pichard, Augusto D.
    Kent, Kenneth M.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2005, 6 (04) : 154 - 159
  • [23] Current Management of In-Stent Restenosis
    Giacoppo, Daniele
    Mazzone, Placido Maria
    Capodanno, Davide
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [24] Current Treatment of In-Stent Restenosis
    Alfonso, Fernando
    Byrne, Robert A.
    Rivero, Fernando
    Kastrati, Adnan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (24) : 2659 - 2673
  • [25] Intravascular Imaging for Guiding In-Stent Restenosis and Stent Thrombosis Therapy
    Erdogan, Emrah
    Bajaj, Retesh
    Lansky, Alexandra
    Mathur, Anthony
    Baumbach, Andreas
    Bourantas, Christos, V
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (22):
  • [26] Treatment of coronary in-stent restenosis: a systematic review
    Pleva, Leos
    Kukla, Pavel
    Hlinomaz, Ota
    JOURNAL OF GERIATRIC CARDIOLOGY, 2018, 15 (02) : 173 - 184
  • [27] Vascular brachytherapy versus drug-eluting stents in the treatment of in-stent restenosis: A meta-analysis of long-term outcomes
    Benjo, Alexandre
    Cardoso, Rhanderson N.
    Collins, Tyrone
    Garcia, Daniel
    Macedo, Francisco Y.
    El-Hayek, Georges
    Nadkarni, Girish
    Aziz, Emad
    Jenkins, J. Stephen
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (02) : 200 - 208
  • [28] Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis
    Megaly, Michael
    Glogoza, Matthew
    Xenogiannis, Iosif
    Vemmou, Evangelia
    Nikolakopoulos, Ilias
    Willson, Laura
    Monyak, David J.
    Sullivan, Patsa
    Stanberry, Larissa
    Sorajja, Paul
    Chavez, Ivan
    Mooney, Michael
    Traverse, Jay
    Wang, Yale
    Garcia, Santiago
    Poulose, Anil
    Burke, Martin Nicholas
    Brilakis, Emmanouil S.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (01) : 32 - 38
  • [29] Intracoronary Brachytherapy For Treatment of In-stent Restenosis in Drug Eluting Stents is Safe and Effective
    Singh, Jaspreet
    Doshi, Rajkumar P.
    Shah, Niraj
    Srinivas, Guru
    Jauhar, Rajiv
    Kavanaugh-Hogans, Marisa
    Kaplan, Barry
    Meraj, Perwaiz
    CIRCULATION, 2015, 132
  • [30] Drug-Eluting Stents vs Intracoronary Brachytherapy for In-Stent Restenosis: A Meta-Analysis
    Lu, Yong-Guang
    Chen, Yan-Mei
    Li, Lang
    Zhao, Rong-Zhen
    Fu, Chun-Hui
    Yan, Hua
    CLINICAL CARDIOLOGY, 2011, 34 (06) : 344 - 351
12345